Company Directory > Biotech > Japan Institute for Health Security
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Japan Institute for Health Security and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
The Japan Institute for Health Security (JIHS) is a national statutory public health agency established in April 2025 through the merger of the National Center for Global Health and Medicine (NCGM) and the National Institute of Infectious Diseases (NIID). It serves as Japan's central hub for infectious disease intelligence, research, development, and clinical response. The institute's mission is to build a resilient and secure society by integrating infectious disease surveillance, advanced R&D (including diagnostics, therapeutics, and vaccines), comprehensive clinical care, and international cooperation. It acts as a primary scientific advisor to the Japanese government and collaborates with global health organizations to manage public health emergencies.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Infectious Disease Research & Public Health
SIZE & FINANCIALS
Employees:501-1000
Founded:2025
Ownership:government
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:Research/Discovery
Modalities:Diagnostics, Vaccines, Therapeutics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Africa CDC (Cooperation Agreement 2026), Network of University Medicine (NUM), Germany (MoU 2026)
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Norihiro Kokudo - President
LINKS
Website:jihs.go.jp
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Japan Institute for Health Security. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.